Search Results 1591-1600 of 16036 for ozempic

  1. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  2. Publications - Kunle I. Elegbede, M.D., Ph.D. - Mayo Clinic

    Hassan BA, Sylvester AD, Wescott DJ, Cunningham DL, Elegbede A, Manson PN, Grant MP. An Introduction to The Orbital Buttresses. Plast Reconstr Surg.

  3. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Publications - Aaron M. Potretzke, M.D. - Mayo Clinic

    Jorgenson LC, Navin PJ, Adamo D, Thompson S, Takahashi E, Schmit G, Potretzke T, Venkatesh SK, Potretzke AM, Stish B, Atwell TD.

  5. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Participation ...

  6. News - Wendy J. Sherman, M.D. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  7. Network Neuro-modulation for Mesial Temporal Lobe Epilepsy - Mayo Clinic

    The purpose of this study is to demonstrate the safety and feasibility of chronic mesial temporal lobe epilepsy (MTLE) network recordings with 4 implanted depth ...

  8. Intra-epidermal Nerve Fiber Densities (IENFDs): A Study of Olmsted County Inhabitants and Surrounding Area, Including Normal Subjects, Patients with Neuropathy or Impaired Glucose and Newly Diagnosed Diabetics - Mayo Clinic

    A decreased number is an indication of abnormality, that is, of disease of small nerve fibers (small fiber sensory neuropathy). This study, therefore, may be ...

  9. Neoadjuvant Pembrolizumab - Mayo Clinic

    This multi-institutional, phase 2 clinical trial is studying two doses of pembrolizumab administered prior to surgery (neoadjuvant therapy) and 4 doses ...

  10. Dose Range Finding Study in Sarcopenia - Mayo Clinic

    The purpose of this study is to determine the efficacy of repeat dosing with multiple dose levels of bimagrumab on patient physical function, skeletal muscle ...